Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Aesthetic Plastic Surgery
Published in: Aesthetic Plastic Surgery 3/2016

01-06-2016 | Review

Potential Safety Loophole of Fat Grafting in Breast Cancer Patients

Authors: Xuebing Liang, Yang Wang, Lauren Franzblau, Jiguang Ma

Published in: Aesthetic Plastic Surgery | Issue 3/2016

Login to get access

Abstract

Autologous fat grafting (AFG) accounts for 9.1 % of all cosmetic surgical procedures in the world. Its use has been increasing tremendously in breast reconstruction and produces satisfying outcomes. However, the lack of standard guidelines for routine screening protocols in breast cancer patients before and after AFG warrants consideration of the safety of AFG use in post-mastectomy and post-lumpectomy reconstruction. This manuscript examines AFG in breast reconstruction publications and details the complications, the mechanism of AFG, as well as the relationship between adipose stem cells (ASCs) and cancer recurrence. The ASCs transferred in AFG act as multiple potent stem cells, which can impact cancer recurrence in various ways. Both in vitro and in vivo studies show that ASCs can stimulate the recurrence of breast cancer. Based on a review of existing evidence, we provide recommendations and guidelines for AFG use in breast reconstruction to aid in clinical decision-making. Further investigations are needed to evaluate the long-term clinical safety of AFG as well as the proposed guidelines.

No Level Assigned

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266
Literature
1.
Mazzola RF, Cantarella G, Torretta S, Sbarbati A, Lazzari L et al (2011) Autologous fat injection to face and neck: from soft tissue augmentation to regenerative medicine. Acta Otorhinolaryngol Ital 31:59–69PubMedPubMedCentral
2.
3.
Bishop A, Hong P, Bezuhly M (2014) Autologous fat grafting for the treatment of velopharyngeal insufficiency: state of the art. J Plast Reconstr Aesthet Surg 67:1–8CrossRefPubMed
4.
Cetinkaya A, Devoto MH (2013) Periocular fat grafting: indications and techniques. Curr Opin Ophthalmol 24:494–499CrossRefPubMed
5.
de Weerd L, Weum S, Norderval S (2014) Novel treatment for recalcitrant rectovaginal fistulas: fat injection. Int Urogynecol J 26:139–144CrossRefPubMed
6.
Murphy A, Lalonde DH, Eaton C, Denkler K, Hovius SE et al (2014) Minimally invasive options in Dupuytren’s contracture: aponeurotomy, enzymes, stretching, and fat grafting. Plast Reconstr Surg 134:822e–829eCrossRefPubMed
7.
Coleman SR, Saboeiro AP (2007) Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 119: 775–785; discussion 786–777
8.
Zhong T, McCarthy CM, Price AN, Pusic AL (2013) Evidence-based medicine: breast reconstruction. Plast Reconstr Surg 132:1658–1669CrossRefPubMed
9.
Tsoi B, Ziolkowski NI, Thoma A, Campbell K, O’Reilly D et al (2014) Systematic review on the patient-reported outcomes of tissue-expander/implant vs autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients. J Am Coll Surg 218:1038–1048CrossRefPubMed
10.
Missana MC, Laurent I, Barreau L, Balleyguier C (2007) Autologous fat transfer in reconstructive breast surgery: indications, technique and results. Eur J Surg Oncol 33:685–690CrossRefPubMed
11.
Khouri RK, Rigotti G, Khouri RK Jr, Cardoso E, Marchi A et al (2015) Tissue-engineered breast reconstruction with Brava-assisted fat grafting: a 7-year, 488-patient, multicenter experience. Plast Reconstr Surg 135:643–658CrossRefPubMed
12.
Caviggioli F, Maione L, Forcellini D, Klinger F, Klinger M (2011) Autologous fat graft in postmastectomy pain syndrome. Plast Reconstr Surg 128:349–352CrossRefPubMed
13.
Claro F Jr, Figueiredo JC, Zampar AG, Pinto-Neto AM (2012) Applicability and safety of autologous fat for reconstruction of the breast. Br J Surg 99:768–780CrossRefPubMed
14.
Chaput B, Foucras L, Le Guellec S, Grolleau JL, Garrido I (2013) Recurrence of an invasive ductal breast carcinoma 4 months after autologous fat grafting. Plast Reconstr Surg 131:123e–124eCrossRefPubMed
15.
Smit JM, Tielemans HJ, de Vries B, Tuinder SM (2014) Recurrence of invasive ductal breast carcinoma 10 months after autologous fat grafting. J Plast Reconstr Aesthet Surg 67:e127–e128CrossRefPubMed
16.
Petit JY, Botteri E, Lohsiriwat V, Rietjens M, De Lorenzi F et al (2012) Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol 23:582–588CrossRefPubMed
17.
Petit JY, Rietjens M, Botteri E, Rotmensz N, Bertolini F et al (2013) Evaluation of fat grafting safety in patients with intraepithelial neoplasia: a matched-cohort study. Ann Oncol 24:1479–1484CrossRefPubMed
18.
Agha RA, Fowler AJ, Herlin C, Goodacre TE, Orgill DP (2015) Use of autologous fat grafting for breast reconstruction: a systematic review with meta-analysis of oncological outcomes. J Plast Reconstr Aesthet Surg 68:143–161CrossRefPubMed
19.
Schaffler A, Scholmerich J, Buechler C (2007) Mechanisms of disease: adipokines and breast cancer—endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 3:345–354CrossRefPubMed
20.
Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206CrossRefPubMed
21.
Celis JE, Moreira JM, Cabezon T, Gromov P, Friis E et al (2005) Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 4:492–522CrossRefPubMed
22.
Kato H, Araki J, Doi K, Kuno S, Kinoshita K et al (2014) Normobaric hyperoxygenation enhances initial survival, regeneration, and final retention in fat grafting. Plast Reconstr Surg 134:951–959CrossRefPubMed
23.
Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S et al (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71:2455–2465CrossRefPubMed
24.
Park J, Morley TS, Kim M, Clegg DJ, Scherer PE (2014) Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 10:455–465CrossRefPubMedPubMedCentral
25.
Lohsiriwat V, Curigliano G, Rietjens M, Goldhirsch A, Petit JY (2011) Autologous fat transplantation in patients with breast cancer: “silencing” or “fueling” cancer recurrence? Breast 20:351–357CrossRefPubMed
26.
Bertolini F (2013) Adipose tissue and breast cancer progression: a link between metabolism and cancer. Breast 22:S48–S49CrossRefPubMed
27.
Coleman SR (2001) Structural fat grafts: the ideal filler? Clin Plast Surg 28:111–119PubMed
28.
Rigby JE, Morris JA, Lavelle J, Stewart M, Gatrell AC (2002) Can physical trauma cause breast cancer? Eur J Cancer Prev 11:307–311CrossRefPubMed
29.
Groessl M, Slany A, Bileck A, Gloessmann K, Kreutz D et al (2014) Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts. J Proteome Res 13:4773–4782CrossRefPubMed
30.
Segatto I, Berton S, Sonego M, Massarut S, Perin T et al (2014) Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling. Oncotarget 5:6267–6279CrossRefPubMedPubMedCentral
31.
Kolle SF, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS et al (2013) Enrichment of autologous fat grafts with ex vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 382:1113–1120CrossRefPubMed
32.
Doi K, Tanaka S, Iida H, Eto H, Kato H et al (2013) Stromal vascular fraction isolated from lipo-aspirates using an automated processing system: bench and bed analysis. J Tissue Eng Regen Med 7:864–870CrossRefPubMed
33.
Perez-Cano R, Vranckx JJ, Lasso JM, Calabrese C, Merck B et al (2012) Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol 38:382–389CrossRefPubMed
34.
Kuhbier JW, Bucan V, Reimers K, Strauss S, Lazaridis A et al (2014) Observed changes in the morphology and phenotype of breast cancer cells in direct co-culture with adipose-derived stem cells. Plast Reconstr Surg 134:414–423CrossRefPubMed
35.
Rowan BG, Gimble JM, Sheng M, Anbalagan M, Jones RK et al (2014) Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS ONE 9:e89595CrossRefPubMedPubMedCentral
36.
Eterno V, Zambelli A, Pavesi L, Villani L, Zanini V et al (2014) Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling. Oncotarget 5:613–633CrossRefPubMedPubMedCentral
37.
Walter M, Liang S, Ghosh S, Hornsby PJ, Li R (2009) Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28:2745–2755CrossRefPubMedPubMedCentral
38.
Devarajan E, Song YH, Krishnappa S, Alt E (2012) Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer 131:1023–1031CrossRefPubMed
39.
Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS et al (2012) Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci U S A 109:9786–9791CrossRefPubMedPubMedCentral
40.
Senst C, Nazari-Shafti T, Kruger S, Honer Zu Bentrup K, Dupin CL et al (2013) Prospective dual role of mesenchymal stem cells in breast tumor microenvironment. Breast Cancer Res Treat 137:69–79CrossRefPubMed
41.
Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC et al (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035–3039PubMed
42.
Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM et al (2014) Breast cancer in China. Lancet Oncol 15:e279–e289CrossRefPubMed
43.
DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62CrossRefPubMed
44.
Chagpar AB, Killelea BK, Tsangaris TN, Butler M, Stavris K et al (2015) A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med 373:503–510CrossRefPubMed
45.
Krastev TK, Jonasse Y, Kon M (2013) Oncological safety of autologous lipoaspirate grafting in breast cancer patients: a systematic review. Ann Surg Oncol 20:111–119CrossRefPubMed
46.
Gale KL, Rakha EA, Ball G, Tan VK, McCulley SJ et al (2015) A case-controlled study of the oncologic safety of fat grafting. Plast Reconstr Surg 135:1263–1275CrossRefPubMed
47.
Escobar PF, Patrick RJ, Rybicki LA, Weng DE, Crowe JP (2007) The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups. Ann Surg Oncol 14:143–147CrossRefPubMed
48.
Courdi A, Doyen J, Gal J, Chamorey E (2010) Local recurrence after breast cancer affects specific survival differently according to patient age. Oncology 79:349–354CrossRefPubMed
49.
Nixon AJ, Schnitt SJ, Gelman R, Gage I, Bornstein B et al (1996) Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer 78:1426–1431CrossRefPubMed
50.
Norum JH, Andersen K, Sorlie T (2014) Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy. Br J Surg 101:925–938CrossRefPubMed
51.
Boyle P (2012) Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 23 (Suppl 6):vi7–12
52.
Marsden J (2002) The menopause, hormone replacement therapy and breast cancer. J Steroid Biochem Mol Biol 83:123–132CrossRefPubMed
53.
Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJ et al (2014) Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study. Breast Cancer Res Treat 145:185–192CrossRefPubMed
54.
van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009CrossRefPubMed
55.
Munoz M, Estevez LG, Alvarez I, Fernandez Y, Margeli M et al (2008) Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer. Cancer Treat Rev 34:701–709CrossRefPubMed
56.
Boughey JC, Dietz J (2014) Providing the best care for patients with breast cancer through use of the multidisciplinary team. Ann Surg Oncol 21:3163–3165CrossRefPubMed
57.
58.
59.
Krumboeck A, Giovanoli P, Plock JA (2013) Fat grafting and stem cell enhanced fat grafting to the breast under oncological aspects–recommendations for patient selection. Breast 22:579–584CrossRefPubMed
60.
Salgarello M, Visconti G, Barone-Adesi L (2012) Fat grafting and breast reconstruction with implant: another option for irradiated breast cancer patients. Plast Reconstr Surg 129:317–329CrossRefPubMed
61.
Veber M, Tourasse C, Toussoun G, Moutran M, Mojallal A et al (2011) Radiographic findings after breast augmentation by autologous fat transfer. Plast Reconstr Surg 127:1289–1299CrossRefPubMed
62.
Hayes DF (2007) Clinical practice. Follow-up of patients with early breast cancer. N Engl J Med 356:2505–2513CrossRefPubMed
63.
Carvajal J, Patino JH (2008) Mammographic findings after breast augmentation with autologous fat injection. Aesthet Surg J 28:153–162CrossRefPubMed
64.
Boonlikit S (2013) Comparison of mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening in asymptomatic women. Asian Pac J Cancer Prev 14:7731–7736CrossRefPubMed
65.
Costantini M, Cipriani A, Belli P, Bufi E, Fubelli R et al (2013) Radiological findings in mammary autologous fat injections: a multi-technique evaluation. Clin Radiol 68:27–33CrossRefPubMed
66.
67.
Eto H, Kato H, Suga H, Aoi N, Doi K et al (2012) The fate of adipocytes after nonvascularized fat grafting: evidence of early death and replacement of adipocytes. Plast Reconstr Surg 129:1081–1092CrossRefPubMed
Metadata
Title
Potential Safety Loophole of Fat Grafting in Breast Cancer Patients
Authors
Xuebing Liang
Yang Wang
Lauren Franzblau
Jiguang Ma
Publication date
01-06-2016
Publisher
Springer US
Published in
Aesthetic Plastic Surgery / Issue 3/2016
Print ISSN: 0364-216X
Electronic ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-016-0634-9

Other articles of this Issue 3/2016

Aesthetic Plastic Surgery 3/2016 Go to the issue

Original Article

Noninvasive Shock Wave Treatment for Capsular Contractures After Breast Augmentation: A Rabbit Study

Original Article

Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides

Original Article

Total Abdominal Wall Reconstruction with Component Separation, Reinforcement, and Vertical Abdominoplasty in Patients with Complex Ventral Hernias

Review

Creating the Perfect Umbilicus: A Systematic Review of Recent Literature

Case Report

Abdominal Wall Defect Reconstructed by Breast Flaps Using a Mercedes Closure Pattern

Original Article

An Islanded Rabbit Auricular Skin Flap Model of Hyaluronic Acid Injection-Induced Embolism